106 related articles for article (PubMed ID: 1326725)
1. IgG subclass responses in brain and serum in Semliki Forest virus demyelinating encephalitis.
Parsons LM; Webb HE
Neuropathol Appl Neurobiol; 1992 Aug; 18(4):351-9. PubMed ID: 1326725
[TBL] [Abstract][Full Text] [Related]
2. Identification of immunoglobulin-containing cells in the central nervous system of the mouse following infection with the demyelinating strain of Semliki Forest virus.
Parsons LM; Webb HE
Br J Exp Pathol; 1989 Jun; 70(3):247-55. PubMed ID: 2548561
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin synthesis in nude (nu/nu), nu/+ and reconstituted nu/nu mice infected with a demyelinating strain of Semliki Forest virus.
Suckling AJ; Jagelman S; Webb HE
Clin Exp Immunol; 1982 Feb; 47(2):283-8. PubMed ID: 6280913
[TBL] [Abstract][Full Text] [Related]
4. Semliki Forest virus induced, immune mediated demyelination: the effect of irradiation.
Fazakerley JK; Webb HE
Br J Exp Pathol; 1987 Feb; 68(1):101-13. PubMed ID: 3028463
[TBL] [Abstract][Full Text] [Related]
5. Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis.
Amor S; Scallan MF; Morris MM; Dyson H; Fazakerley JK
J Gen Virol; 1996 Feb; 77 ( Pt 2 )():281-91. PubMed ID: 8627232
[TBL] [Abstract][Full Text] [Related]
6. The role of complement in monoclonal antibody-mediated protection against virulent Semliki Forest virus.
Boere WA; Benaissa-Trouw BJ; Harmsen T; Erich T; Kraaijeveld CA; Snippe H
Immunology; 1986 Aug; 58(4):553-9. PubMed ID: 3015781
[TBL] [Abstract][Full Text] [Related]
7. Semliki Forest virus-induced, immune-mediated demyelination: adoptive transfer studies and viral persistence in nude mice.
Fazakerley JK; Webb HE
J Gen Virol; 1987 Feb; 68 ( Pt 2)():377-85. PubMed ID: 3029281
[TBL] [Abstract][Full Text] [Related]
8. Blood brain barrier disturbance and immunoglobulin G levels in the cerebrospinal fluid of the mouse following peripheral infection with the demyelinating strain of Semliki Forest virus.
Parsons LM; Webb HE
J Neurol Sci; 1982 Dec; 57(2-3):307-18. PubMed ID: 6298371
[TBL] [Abstract][Full Text] [Related]
9. A protective monoclonal anti-idiotypic vaccine to lethal Semliki Forest virus infection in BALB/c mice.
Oosterlaken TA; Harmsen M; Jhagjhoor-Singh SS; Ekstijn GL; Kraaijeveld CA; Snippe H
J Virol; 1991 Jan; 65(1):98-102. PubMed ID: 1845911
[TBL] [Abstract][Full Text] [Related]
10. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system: consequences in BALB/c and SJL mice.
Smyth JM; Sheahan BJ; Atkins GJ
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2575-83. PubMed ID: 2174955
[TBL] [Abstract][Full Text] [Related]
11. Immunological reaction of the demyelinating Semliki Forest virus with immune serum to glycolipids and its possible importance to central nervous system viral auto-immune disease.
Webb HE; Mehta S; Gregson NA; Leibowitz S
Neuropathol Appl Neurobiol; 1984; 10(2):77-84. PubMed ID: 6328340
[TBL] [Abstract][Full Text] [Related]
12. The effect of mouse strain on the pathogenesis of the encephalitis and demyelination induced by avirulent Semliki Forest virus infections.
Suckling AJ; Jagelman S; Illavia SJ; Webb HE
Br J Exp Pathol; 1980 Jun; 61(3):281-4. PubMed ID: 6252935
[TBL] [Abstract][Full Text] [Related]
13. Properties of host and virus which influence defective interfering virus mediated-protection of mice against Semliki Forest virus lethal encephalitis. Brief report.
Barrett AD; Dimmock NJ
Arch Virol; 1984; 81(1-2):185-8. PubMed ID: 6331348
[TBL] [Abstract][Full Text] [Related]
14. In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection.
Subak-Sharpe I; Dyson H; Fazakerley J
J Virol; 1993 Dec; 67(12):7629-33. PubMed ID: 7901429
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection.
Morris MM; Dyson H; Baker D; Harbige LS; Fazakerley JK; Amor S
J Neuroimmunol; 1997 Apr; 74(1-2):185-97. PubMed ID: 9119972
[TBL] [Abstract][Full Text] [Related]
16. CNS pathogenesis following a dual viral infection with Semliki Forest (alphavirus) and Langat (flavivirus).
Amor S; Webb HE
Br J Exp Pathol; 1988 Apr; 69(2):197-208. PubMed ID: 2837265
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of Semliki forest virus infected mice, induces immune mediated pathological changes in the CNS.
Fazakerley JK; Amor S; Webb HE
Clin Exp Immunol; 1983 Apr; 52(1):115-20. PubMed ID: 6305540
[TBL] [Abstract][Full Text] [Related]
18. A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes.
Kraaijeveld CA; Oosterlaken TA; Snijders A; Benaissa-Trouw BJ; Ekstijn GL; Snippe H
Antiviral Res; 1992 Oct; 19(4):275-84. PubMed ID: 1281391
[TBL] [Abstract][Full Text] [Related]
19. The effect of cycloleucine on SFV A7(74) infection in mice.
Amor S; Webb HE
Br J Exp Pathol; 1987 Apr; 68(2):225-35. PubMed ID: 3034321
[TBL] [Abstract][Full Text] [Related]
20. Following Acute Encephalitis, Semliki Forest Virus is Undetectable in the Brain by Infectivity Assays but Functional Virus RNA Capable of Generating Infectious Virus Persists for Life.
Fragkoudis R; Dixon-Ballany CM; Zagrajek AK; Kedzierski L; Fazakerley JK
Viruses; 2018 May; 10(5):. PubMed ID: 29783708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
